U-M Rogel Cancer Center researchers awarded more than $23 million in grants
University of Michigan Rogel Cancer Center researchers received more than $23 million in grants in June and July, 2017. Highlights include:

Arul Chinnaiyan, M.D., Ph.D., was awarded $225,000 from the Prostate Cancer Foundation for ”A Comprehensive Transcriptomics Resource to Enable Understanding and Clinical Detection of Aggressive Prostate Cancer.”
John Moran, Ph.D., was awarded $371,925 from the NCI for “Identification of Host Factors Governing Alu Retrotransposition in Human Cancer Cell Lines.”
Matthew Soellner, Ph.D., was awarded $619,287 from the NCI for “Exquisitely selective turn-on probes of kinase activation and localization.”
Weiping Zou, Ph.D., was awarded $3,162,518 from the NIH for “Naive T cells in Cancer Immune Evasion and Immunotherapy.”
Gary Fisher, Ph.D., was awarded $1,596,780 from the NIH for “Control of aging and age-related diseases by extracellular matrix microenvironment.”
Jeremy Taylor, Ph.D., was awarded a competitive grant renewal of $1,366,355 from the NCI for “Statistical Methods for Cancer Biomarkers.”
Jacques Nor, D.D.S., M.S., Ph.D., was awarded a competitive grant renewal of $1,840,625 from the NIH for “Perivascular niche for salivary gland cancer stem cells and resistance to therapy.”